Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma

BackgroundCraniopharyngioma is a benign tumor originating from the sellar region. Damages in this area caused by the tumor itself, surgery, or radiotherapy may result in severe hypothalamic-pituitary dysfunction (HPD) and eventually lead to a significant impairment in the long-term quality of life o...

Full description

Bibliographic Details
Published in:	Frontiers in Endocrinology
Main Authors:	Ying Guo, Lili Pei, Yuzheng Li, Chunde Li, Songbai Gui, Ming Ni, Pinan Liu, Yazhuo Zhang, Liyong Zhong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Subjects:	clinical prognosis hypothalamic syndrome endocrine function papillary craniopharyngioma adamantinomatous craniopharyngioma
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1180591/full

Similar Items

Characteristics and influencing factors of neuroendocrine dysfunction in patients with adult-onset craniopharyngioma
by: Ying Guo, et al.
Published: (2025-09-01)

Recent advances in craniopharyngioma pathophysiology and emerging therapeutic approaches
by: Clariano Pires de Oliveira Neto, et al.
Published: (2025-05-01)

A case-based review of adult-onset craniopharyngioma
by: Scott Meyer, et al.
Published: (2025-05-01)

Practical application of precision oncology in adult onset craniopharyngiomas
by: Chandrima Biswas, et al.
Published: (2024-11-01)

Non-Invasive Radiomics Approach Predict Invasiveness of Adamantinomatous Craniopharyngioma Before Surgery
by: Guofo Ma, et al.
Published: (2021-02-01)

The molecular pathogenesis of craniopharyngiomas
by: Marina Lanciotti Campanini, et al.
Published: (2023-02-01)

Bariatric surgery for hypothalamic obesity in patients with craniopharyngioma: A literature review
by: Hui-zheng Hu, et al.
Published: (2023-12-01)

Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review
by: Ao Chen, et al.
Published: (2023-12-01)

Ferroptosis-related biomarkers for adamantinomatous craniopharyngioma treatment: conclusions from machine learning techniques
by: Ying Feng, et al.
Published: (2024-11-01)

A rare case of intratumoral hemorrhage in a young adult with adamantinomatous craniopharyngioma
by: Ana Agustina, MD, et al.
Published: (2025-01-01)

Targeted Therapy in the Management of Modern Craniopharyngiomas
by: Maikerly Reyes, et al.
Published: (2022-04-01)

Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas
by: Lu Jin, et al.
Published: (2023-10-01)

Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma
by: Lukas Andereggen, et al.
Published: (2024-02-01)

Tocilizumab for the fifth progression of cystic childhood craniopharyngioma—a case report
by: Evelien de Vos-Kerkhof, et al.
Published: (2023-10-01)

Craniopharyngioma – case report and literature review
by: Michał Leśniewski
Published: (2024-02-01)

Obesity and craniopharyngioma
by: Bruzzi Patrizia, et al.
Published: (2011-08-01)

Fatigue in patients with hypothalamic syndrome – A cross-sectional analysis of the German childhood-onset craniopharyngioma cohort
by: Julia Beckhaus, et al.
Published: (2024-12-01)

Obesity in patients with craniopharyngioma in the South Asian region – A distinct phenotype
by: Sreevatsa Tatachar, et al.
Published: (2024-12-01)

Treatment with BRAF/MEK: inhibitors in mutant BRAF V600E papillary craniopharyngioma
by: Eva Marie Erfurth, et al.
Published: (2024-12-01)

Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma
by: Yuqi Miao, et al.
Published: (2023-11-01)

Distinction of papillary and adamantinomatous craniopharyngioma: Clinical features, surgical nuances and hypothalamic outcomes
by: Le Yang, et al.
Published: (2024-11-01)

Single-cell and spatial sequencing identifies senescent and germinal tumor cells in adamantinomatous craniopharyngiomas
by: Xianlong Wang, et al.
Published: (2024-09-01)

Endoscopic transsphenoidal surgery for infradiaphragmatic craniopharyngiomas and impact of diaphragm sellae competence on hypothalamic injury
by: Xuan Gong, et al.
Published: (2024-12-01)

Methylation and gene expression patterns in adamantinomatous craniopharyngioma highlight a panel of genes associated with disease progression-free survival
by: Junier Marrero-Gutiérrez, et al.
Published: (2025-06-01)

Childhood craniopharyngioma: a retrospective study of children followed in Hôpital Universitaire de Bruxelles
by: Clémentine Magerman, et al.
Published: (2024-06-01)

Editorial: Recent advances in pediatric craniopharyngioma
by: Hermann L. Müller, et al.
Published: (2024-04-01)

Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases
by: Wei Wu, et al.
Published: (2021-07-01)

Recent Advances in Diet and Exercise Interventions towards Craniopharyngioma-related Hypothalamic Obesity
by: REN Ying, WANG Chaohu, ZHANG Nannan, BAO Yun, QI Songtao, DENG Yingying
Published: (2024-07-01)

Aggressive surgical management of craniopharyngiomas
by: Manmohan Singh, et al.
Published: (2013-05-01)

MELATONIN SECRETION AND HYPERSOMNIA IN CHILDREN AND ADOLESCENTS AFTER CRANIOPHARYNGIOMA RESECTION
by: E. Yu. Il'ina, et al.
Published: (2012-09-01)

Metabolic syndrome as a common comorbidity in adults with hypothalamic dysfunction
by: Zhuoran Xu, et al.
Published: (2022-10-01)

Craniopharyngioma: A comprehensive review of the clinical presentation, radiological findings, management, and future Perspective
by: Maryam Nashi Alboqami, et al.
Published: (2024-06-01)

Gut microbiota composition and metabolic characteristics in patients with Craniopharyngioma
by: Chunhui Liu, et al.
Published: (2024-04-01)

Could setmelanotide be the game-changer for acquired hypothalamic obesity?
by: Hanneke M. van Santen, et al.
Published: (2024-01-01)

BMI trajectories in the first 3 months after childhood craniopharyngioma resection: a plea for early management of BMI changes
by: S C Hulsmann, et al.
Published: (2025-02-01)

Changing Epidemiology of Pediatric Brain Tumors
by: J Gordon Millichap
Published: (2009-07-01)

Cell signaling communication within papillary craniopharyngioma revealed by an integrated analysis of single-cell RNA sequencing and bulk RNA sequencing
by: Xiaoyue Zhu, et al.
Published: (2025-01-01)

Alterations of Brain Structural and Functional Connectivity Networks and Its Correlations With Cognitive Function in Patients With Hypothalamic Syndrome Following Craniopharyngioma Resection
by: Shuang Li, et al.
Published: (2025-08-01)

Comparative analysis of clinical features, methylation and immune microenvironment in pediatric and adult papillary craniopharyngiomas: results from a multicenter study
by: Ning Luo, et al.
Published: (2025-07-01)

Prospects of BRAF/MEK Inhibitor Therapy in Papillary Craniopharyngiomas with the BRAF V600E Mutation: A Scoping Review
by: Shingo FUJIO, et al.
Published: (2025-05-01)